US Edition
FDA recommends concentrated Kratom be scheduled as illicit substance
UNITED STATES, JUL 29 – FDA urges classifying synthetic 7-hydroxymitragynine as Schedule I to curb opioid-like abuse while maintaining legal access to natural kratom used by over 24 million Americans.
- On July 29, 2025, U.S. health officials proposed adding 7-hydroxymitragynine , a compound found in kratom, to the list of Schedule I controlled substances.
- This action responds to rising concerns about synthetic 7-OH products that mimic opioids and pose health risks, unlike largely unregulated natural kratom.
- The FDA previously sent warning letters on July 15, 2025, to seven companies marketing concentrated 7-OH in tablets, gummies, and drinks, stating these products may be dangerous.
- FDA Commissioner Marty Makary emphasized that the focus is on the synthetic opioid derivative 7-hydroxymitragynine because of its addictive qualities, rather than on the natural kratom leaf or its ground form.
- The scheduling is intended to protect consumers from harmful synthetic products while preserving safe access to natural kratom used regularly by over 24 million Americans.
100 Articles
100 Articles
FDA Marks 7-OH, Kratom Compound With Opioid Effect, for CSA Schedule I
The Food and Drug Administration is recommending that 7-hydroxymitragynine, commonly referred to as 7-OH, be federally scheduled under the Controlled Substances Act. The agency announced July 29 that it had initiated the review process with the Drug Enforcement Administration, and FDA Commissioner Marty Makary has suggested that 7-OH should be classified as Schedule I. 7-OH is an active byproduct of mitragynine, which is the main psychoactive co…
Chippewa Herald
Winona Daily NewsUS cracks down on kratom-linked products
WASHINGTON — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban.
State Rep calls 7-OH in kratom products the 'Wild Wild West' as FDA asks for ban
TAMPA, Fla (WFLA) -- The Food and Drug Administration wants to ban an opioid-like substance sold in gas stations and convenience stores. "Let's not allow another wave of the opioid epidemic to catch us blindsided again," said FDA Commissioner Dr. Marty McCreery. Auto insurance rates down 7% for 2025, DeSantis says Leaders with the FDA, the Drug Enforcement Administration and the U.S. Department of Health and Human Services said products co…
FDA urges crackdown on 7-OH, a potent opioid-like substance sold in gas stations
Federal health officials are calling for urgent action against a powerful, unregulated substance being sold in gas stations, vape shops, and convenience stores across the country.
West Virginia attorney warns of dangers of legal drug Kratom
CHARLESTON, W.Va. (WOWK) — A West Virginia attorney said a highly addictive drug that is causing serious health problems can be purchased on the shelves at gas stations. Kratom, in its natural leaf state, is a medicine used in eastern parts of the world, but in its synthetic form, 7-Hydroxymitragynine (7-OH), the drug causes issues like heart attacks, strokes and sudden death. "It's highly addictive. It's the opioid of gas stations that can caus…
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
